• 22. November 2024

Anergis Announces Completion of Treatment in AllerT Phase II Dose-Ranging Trial

ByAnergis SA

Apr 1, 2015
#8722 213 patients included in trial of novel ultra-fast allergy immunotherapeutic
Teile den Beitrag mit Freunden

Kommentar verfassen